Richard D. Hockett
Nessuna posizione attualmente
Profilo
Richard D.
Hockett worked as the Head of Genomic Medicine at Eli Lilly & Co. He then served as the Chief Medical Officer at Affymetrix, Inc. and CombiMatrix Corp.
before becoming the Chief Medical Officer at Biodesix, Inc. Hockett holds a doctorate degree from the University of Minnesota.
Precedenti posizioni note di Richard D. Hockett
Società | Posizione | Fine |
---|---|---|
COMBIMATRIX CORP | Chief Tech/Sci/R&D Officer | 28/02/2014 |
AFFYMETRIX, INC. | Chief Tech/Sci/R&D Officer | 01/04/2012 |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
BIODESIX, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Richard D. Hockett
University of Minnesota | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
BIODESIX, INC. | Health Services |
Aziende private | 2 |
---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
CombiMatrix Corp.
CombiMatrix Corp. BiotechnologyHealth Technology CombiMatrix Corp. engages in the provision of clinical diagnostic services. It offers cytogenomic testing for preimplantation genetic testing, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. The company was founded in October 1995 and is headquartered in Irvine, CA. | Health Technology |
- Borsa valori
- Insiders
- Richard D. Hockett